UCB
UCB is number 863 in the 311 Titans Index of the world's largest companies, with reported revenue of about $8.4bn in . It is headquartered in Brussels-Capital Region, Belgium. In short: Biopharmaceutical company headquartered in Brussels, Belgium. 311 Future Exposure: medium (43/100), driven by technology change in healthcare (76/100), led by 5G, Artificial Narrow Intelligence, Biometric Sensors.
Part of the 311 Titans Index (311institute.com). Last updated .
311 Future Exposure: Medium
Score 43 out of 100: technology 76/100 and trends 10/100. What drives it:
- Technology change in healthcare (76/100), led by 5G, Artificial Narrow Intelligence, Biometric Sensors
Technology exposure uses the 311 Starburst: how strongly each emerging technology affects this industry, weighted by how soon it reaches widespread use. Trend exposure covers tariffs and export controls, international sanctions. Evidence on company-specific trends is being added. Explore the Starburst.
Other Titans in Belgium
- Anheuser-Busch InBev (#130)
- Colruyt Group (#631)
- D'Ieteren Group (#821)
- SYENSQO (#1054)
- Ackermans & van Haaren (#1055)
- NV Bekaert SA (#1424)
- Econocom Group (#1664)
- Orange Belgium (#2086)
- Ageas (#F80)
- KBC Group (#F113)
- Groupe Bruxelles Lambert (#F170)
Related
Questions and answers
How big is UCB?
UCB reported revenue of about $8.4bn in , ranking number 863 in the 311 Titans Index.
Where is UCB headquartered?
UCB is headquartered in Brussels-Capital Region, Belgium.
Source: Wikidata (company-reported figure).
© 311 Institute 2026. Facts from official filings, Wikidata (CC0) and the sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.